Tong Ren Tang Technologies Co. Ltd. (FRA:TNG)
Germany · Delayed Price · Currency is EUR | Market Cap | 434.62M -35.4% |
| Revenue (ttm) | 743.48M -17.0% |
| Net Income | 39.53M -28.9% |
| EPS | 0.03 -28.9% |
| Shares Out | n/a |
| PE Ratio | 10.37 |
| Forward PE | 7.18 |
| Dividend | 0.02 (6.99%) |
| Ex-Dividend Date | Jun 16, 2026 |
| Volume | 100 |
| Open | 0.3280 |
| Previous Close | 0.3220 |
| Day's Range | 0.3260 - 0.3280 |
| 52-Week Range | 0.3000 - 0.5300 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About FRA:TNG
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through three segments: The Company; Tong Ren Tang Chinese Medicine; and Others. The company develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products. It also offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics.... [Read more]
Financial Performance
In 2025, FRA:TNG's revenue was 6.48 billion, a decrease of -10.69% compared to the previous year's 7.26 billion. Earnings were 396.28 million, a decrease of -24.06%.
Financial numbers in CNY Financial StatementsNews
Chinese Medicine Firm Seeks Elusive Elixir Of IPO Success
The healthcare services arm of the Tong Ren Tang group enjoys a high-profile TCM brand, but its profit margins lag far behind industry peers Key Takeaways: Tong Ren Tang Healthcare ranks as China's bi...